Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of MMB4 DMS in Healthy Volunteers
NCT02018250Phase 1Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Mar 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MMB4 DMS in organophosphate poisoning (5 arms), sponsored by U.S. Army Medical Research and Development Command. Primary endpoint: Number of Adverse Events at 30 days. Started Mar 2012; status: completed.
02
Drugs
MMB4 DMS
03
Conditions
organophosphate poisoning
Beyond the preview
Go deeper on NCT02018250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02018250.